RU2004110934A - 17 альфа-гидрокси-14бета-стероиды с гормональным эффектом - Google Patents
17 альфа-гидрокси-14бета-стероиды с гормональным эффектом Download PDFInfo
- Publication number
- RU2004110934A RU2004110934A RU2004110934/04A RU2004110934A RU2004110934A RU 2004110934 A RU2004110934 A RU 2004110934A RU 2004110934/04 A RU2004110934/04 A RU 2004110934/04A RU 2004110934 A RU2004110934 A RU 2004110934A RU 2004110934 A RU2004110934 A RU 2004110934A
- Authority
- RU
- Russia
- Prior art keywords
- steroid compound
- compound according
- hydroxy
- 14beta
- steroids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Claims (7)
1. Стероидное соединение формулы I
в которой R1 представляет О, (Н,Н), (Н,ОН), NOH, где ОН необязательно этерифицирована или эстерифицирована;
R2 и R3 независимо представляют водород или (С1-4)алкил, и, по меньшей мере, один из R2 и R3 представляет (С1-4)алкил;
R4 представляет водород или (С1-15)ацил.
2. Производное стероидного соединения по п.1, где R1 представляет О, и, по меньшей мере, один из R2 и R3 представляет метил, и другой является водородом или метилом.
3. Производное стероидного соединения по п.2, которое представляет собой (7,14,16,17)-17-гидрокси-7,16-диметилэстр-4-ен-3-он.
4. Стероидное соединение по любому из пп.1-3 для применения для лечения.
5. Применение стероидного соединения по любому из пп.1-3 для производства лекарственного средства для применения в лечении, связанном с андрогенами.
6. Применение по п.5, где лечение направлено на контрацепцию у мужчин или гормональную заместительную терапию у мужчин или женщин.
7. Способ лечения животного или человека при необходимости андрогенной стимуляции для получения андрогенного эффекта, отличающийся тем, что эффективную дозу стероидного соединения по любому из пп.1-3 вводят животному или человеку.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01203455.9 | 2001-09-12 | ||
| EP01203455 | 2001-09-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2004110934A true RU2004110934A (ru) | 2005-08-20 |
| RU2294332C2 RU2294332C2 (ru) | 2007-02-27 |
Family
ID=8180920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2004110934/04A RU2294332C2 (ru) | 2001-09-12 | 2002-09-06 | Стероидное соединение, его применение и способ лечения |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US7169769B2 (ru) |
| EP (1) | EP1427748B1 (ru) |
| JP (1) | JP4471653B2 (ru) |
| KR (1) | KR100940054B1 (ru) |
| CN (1) | CN1257913C (ru) |
| AR (1) | AR036462A1 (ru) |
| AT (1) | ATE395352T1 (ru) |
| AU (1) | AU2002339536B2 (ru) |
| BR (1) | BR0212409A (ru) |
| CA (1) | CA2505575C (ru) |
| CY (1) | CY1108152T1 (ru) |
| DE (1) | DE60226623D1 (ru) |
| DK (1) | DK1427748T3 (ru) |
| EC (1) | ECSP045012A (ru) |
| ES (1) | ES2305306T3 (ru) |
| HK (1) | HK1063637A1 (ru) |
| HR (1) | HRP20040193A2 (ru) |
| HU (1) | HUP0402139A3 (ru) |
| IL (2) | IL160451A0 (ru) |
| IS (1) | IS2555B (ru) |
| MX (1) | MXPA04002418A (ru) |
| NO (1) | NO326624B1 (ru) |
| NZ (1) | NZ531487A (ru) |
| PL (1) | PL207493B1 (ru) |
| PT (1) | PT1427748E (ru) |
| RU (1) | RU2294332C2 (ru) |
| TW (1) | TWI221154B (ru) |
| WO (1) | WO2003022864A1 (ru) |
| ZA (1) | ZA200401992B (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI221154B (en) | 2001-09-12 | 2004-09-21 | Akzo Nobel Nv | 17alpha-hydroxy-14beta-steroids with hormonal effect |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3338925A (en) * | 1965-10-25 | 1967-08-29 | Syntex Corp | 17-substituted 14beta-estr-4-enes |
| AU3162200A (en) * | 1999-03-08 | 2000-09-28 | Akzo Nobel N.V. | 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens |
| US6905714B2 (en) * | 2000-02-29 | 2005-06-14 | National University Of Singapore | Method for modulating steroidogenic activity |
| US6391868B2 (en) * | 2000-05-10 | 2002-05-21 | Lpt Research, Inc. | Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans |
| TWI221154B (en) | 2001-09-12 | 2004-09-21 | Akzo Nobel Nv | 17alpha-hydroxy-14beta-steroids with hormonal effect |
-
2002
- 2002-07-19 TW TW091116164A patent/TWI221154B/zh not_active IP Right Cessation
- 2002-09-06 AU AU2002339536A patent/AU2002339536B2/en not_active Expired
- 2002-09-06 DK DK02777036T patent/DK1427748T3/da active
- 2002-09-06 PT PT02777036T patent/PT1427748E/pt unknown
- 2002-09-06 IL IL16045102A patent/IL160451A0/xx unknown
- 2002-09-06 HU HU0402139A patent/HUP0402139A3/hu unknown
- 2002-09-06 DE DE60226623T patent/DE60226623D1/de not_active Expired - Lifetime
- 2002-09-06 AT AT02777036T patent/ATE395352T1/de active
- 2002-09-06 ES ES02777036T patent/ES2305306T3/es not_active Expired - Lifetime
- 2002-09-06 BR BR0212409-2A patent/BR0212409A/pt not_active IP Right Cessation
- 2002-09-06 CA CA2505575A patent/CA2505575C/en not_active Expired - Lifetime
- 2002-09-06 JP JP2003526937A patent/JP4471653B2/ja not_active Expired - Fee Related
- 2002-09-06 CN CNB02817853XA patent/CN1257913C/zh not_active Expired - Lifetime
- 2002-09-06 EP EP02777036A patent/EP1427748B1/en not_active Expired - Lifetime
- 2002-09-06 WO PCT/EP2002/010041 patent/WO2003022864A1/en active IP Right Grant
- 2002-09-06 NZ NZ531487A patent/NZ531487A/en not_active IP Right Cessation
- 2002-09-06 US US10/489,456 patent/US7169769B2/en not_active Expired - Lifetime
- 2002-09-06 RU RU2004110934/04A patent/RU2294332C2/ru not_active IP Right Cessation
- 2002-09-06 KR KR1020047003609A patent/KR100940054B1/ko not_active IP Right Cessation
- 2002-09-06 MX MXPA04002418A patent/MXPA04002418A/es active IP Right Grant
- 2002-09-06 PL PL368727A patent/PL207493B1/pl not_active IP Right Cessation
- 2002-09-10 AR ARP020103415A patent/AR036462A1/es unknown
-
2004
- 2004-02-18 IL IL160451A patent/IL160451A/en not_active IP Right Cessation
- 2004-02-26 IS IS7165A patent/IS2555B/is unknown
- 2004-02-26 HR HR20040193A patent/HRP20040193A2/hr not_active Application Discontinuation
- 2004-03-10 EC EC2004005012A patent/ECSP045012A/es unknown
- 2004-03-10 NO NO20041010A patent/NO326624B1/no not_active IP Right Cessation
- 2004-03-11 ZA ZA200401992A patent/ZA200401992B/en unknown
- 2004-08-24 HK HK04106336A patent/HK1063637A1/xx not_active IP Right Cessation
-
2008
- 2008-06-19 CY CY20081100653T patent/CY1108152T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1320132C (en) | Dehydroepiandrosterone therapy | |
| ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| DE69022722D1 (de) | Kombinationstherapie zur behandlung von estrogenempfindlichen erkrankungen. | |
| AR071419A1 (es) | Composiciones y metodos de tratamiento del cancer de mama | |
| DE50112561D1 (de) | 8.beta.-hydrocarbyl-substituierte estratriene als selektiv wirksame estrogene | |
| RU2005108133A (ru) | Дипептиднитрильные ингибиторы катепсина к | |
| RU2001101492A (ru) | ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ АНДРОСТ-5-EH-3-β, 17β-ДИОЛ, И ЕГО ИСПОЛЬЗОВАНИЕ | |
| EP0641565A1 (en) | Contraceptive and menstrual cycle controlling drug having oncostatic properties | |
| ATE300289T1 (de) | Verwendung von (deaminohydroxy)toremifene zur behandlung von vaginalen trockenheit oder sexuellen störung während und nach der menopause | |
| Tagnon | Antiestrogens in treatment of breast cancer | |
| CA2431645A1 (en) | Methods of treating hormonal deficiencies in women undergoing estrogen replacement therapy | |
| HRP20030387A2 (en) | Use of antiprogestins for prophylaxis and treatment of hormone dependent diseases | |
| EP1166778A3 (en) | The use of growth hormone scretagogues to treat systemic lupus erythematosus and inflammatory bowel disease | |
| RU2002117440A (ru) | Новые андрогены | |
| RU2003136733A (ru) | Пероральное введение паратиреоидного гормона и кальцитонина | |
| JP2003528919A5 (ru) | ||
| KR940021064A (ko) | 프레그네인 유도체의 사용 방법 | |
| RU2002129355A (ru) | Применение фульвестранта при лечении резистентного рака молочной железы | |
| RU2004121162A (ru) | Применение анастрозола для лечения женщин в постклимактерическом периоде, которые страдают ранним раком молочной железы | |
| RU2004110934A (ru) | 17 альфа-гидрокси-14бета-стероиды с гормональным эффектом | |
| Vest et al. | Clinical experiments with androgens: IV. A method of implantation of crystalline testosterone | |
| Appelt et al. | Effects of antiandrogen treatment on the sexuality of women with hyperandrogenism | |
| KR900006360A (ko) | 3β, 17β- 하이드록시-치환된 스테로이드 및 관련 스테로이드성 화합물 | |
| HUP0101005A2 (hu) | Szteroid aromatáz gátlót tartalmazó gyógyszer emlőrák megelőzésére és/vagy kezelésére | |
| DE60202954D1 (de) | Tetrahydrochinolin-derivate zur behandlung von krankheiten ausgelöst durch zu hohem oder zu niedrigem oestrogenspiegel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC4A | Invention patent assignment |
Effective date: 20070510 |
|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20110907 |